Events
Media centre
Careers
Contact
Donate
Search
Activities
Clinical trials
Other research initiatives
Quality assurance
Education & training
Early career
Public policy
Research fields
Tumours
Cross-discipline
Network & partners
Members
Partners & supporters
Government bodies
Liaison offices
Research tools
Study tools
Clinical trials database
Bibliography
Guidelines
Data sharing
About us
Our mission
Strategic overview
Policies
Code of ethical conduct
Funding
History
Governance
Headquarters
Annual Report
Category:
News
News
New statement to replace the FDA 1572 form for non-IND trials supported by NCI
23 Feb
News / Quality of Life Group
PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI
17 Feb
News
When will the EU take treatment optimisation seriously?
15 Feb
News
EORTC embarked on a membership renewal programme
5 Feb
News
Interview of EORTC members about COVID-19 impact on cancer clinical trials
4 Feb
News
PRESS RELEASE: EORTC 1945 OligoRARE trial in oligometastatic rare cancers receives support by Anticancer Fund & Rising Tide Foundation
2 Feb
News
Professor John Gordon McVie BSc (Hons), MBChB, M.D., FRCP, FRCPE, FRCPSGlas, FMedSci, DSc (1945-2021)
22 Jan
Lung Cancer Group / News
PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study
20 Jan
News
Webinar: How can current EU policy initiatives pave the way towards treatment optimisation as part of health systems?
14 Jan
News
EORTC lobbies for reducing the economic burden of cancer by optimising treatment for cancer patients
17 Dec
1
2
3
…
44
»
Activities
Clinical trials
Other research initiatives
Quality assurance
Education & training
Early career
Public policy
Research fields
Tumours
Cross-discipline
Network & partners
Members
Partners & supporters
Government bodies
Liaison offices
Research tools
Study tools
Clinical trials database
Bibliography
Guidelines
Data sharing
About us
Our mission
Strategic overview
Policies
Code of ethical conduct
Funding
History
Governance
Headquarters
Annual Report
This website contains cookies to enhance the user experience.
More information
I understand